What is TD SYNNEX Corporation's earnings per share (EPS)?

TD SYNNEX Corporation (SNX) reported diluted earnings per share of $9.95 for fiscal year 2025. This represents a 25.2% change compared to the previous fiscal year. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

TD SYNNEX Corporation (SNX) Financials

SNX

Trailing 12 months to August 31, 2026

Revenue $75.7B +24.1% YoY

Net Income $1.3B +71.3% YoY

EPS (Diluted) $16.40 +78.1% YoY

Free Cash Flow -$815.0M -269.7% YoY

Market Cap $22.0B as of Oct 14, 2026

Price / Sales 0.3x on $75.7B revenue, trailing 12 months to August 31, 2026

Price / Earnings 16.6x on $1.3B net income, trailing 12 months to August 31, 2026

Price / Book 2.4x on $9.3B equity, Q3 FY2026

A multiple compares the market's price with a filed figure; it says what the market pays, not how the business is doing. The market capitalization is the vendor's as of Oct 14, 2026; every other figure is from the SEC filings on this page. Not financial advice.

Source SEC Filings (10-K/10-Q) Latest period Q3 FY2026, ended Aug 31, 2026 Reported Oct 1, 2026 Currency USD FYE November

Newest figures come from the 10-Q for Q3 FY2026, filed Oct 1, 2026. Each column of the statement tables below links to the filing it was taken from, and every filing is listed on the SNX SEC filings page.

TD SYNNEX Corporation (SNX) reported $75.7B in revenue over the twelve months to Aug 31, 2026, up 24.1% from the prior twelve months. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 15 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Rhea AI SNX FY2025 2026-10-01

TD SYNNEX operates on thin margins, but scale and improving cash conversion make working capital the central operating lever.

The margin improvement is visible across the cycle: operating margin widened from 1.7% in FY2022 to 2.3% in FY2025, while operating cash flow recovered into $1.5B after negative territory. FY2025 free cash flow conversion was also substantial, with $1.4B of free cash flow versus $827.7M of net income, indicating earnings were supported by cash generation after reinvestment.

FY2025 gross margin was 7.0%, while net margin was only 1.3%; this is a volume-heavy model where small efficiency changes can materially affect earnings. Operating margin rose from 1.9% in FY2023 to 2.3% in FY2025, suggesting better cost absorption or mix rather than merely more sales.

Inventory and receivables reached $9.5B and $11.7B in FY2025, making working capital a major funding requirement as the business expands. Current liabilities were $21.0B alongside a 1.2x current ratio, indicating reported short-term coverage remains positive but relatively narrow.

Financial Health Signals

Financial Health Score 48/100

Scored against operating companies for FY2025. Each of the six dimensions is a percentile rank within that peer group; the overall is their average, with missing dimensions counted as zero out of six. A high score means strong standing among peers, not absolute cross-industry strength. How this score is calculated →

Health score ≠ stock price. This rates the quality of TD SYNNEX Corporation's business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.

Profitability

TD SYNNEX Corporation has an operating margin of 2.3%, meaning the company retains $2 of operating profit per $100 of revenue. This results in a moderate score of 55/100, indicating healthy but not exceptional operating efficiency. This is up from 2.0% the prior year.

Growth

TD SYNNEX Corporation's revenue grew 6.9% year-over-year to $62.5B, a solid pace of expansion. This earns a growth score of 46/100.

Leverage

TD SYNNEX Corporation has a moderate D/E ratio of 0.43. This balance of debt and equity financing earns a leverage score of 56/100.

Liquidity

TD SYNNEX Corporation's current ratio of 1.21 is below the typical benchmark, resulting in a score of 29/100. This tight liquidity could limit financial flexibility if cash inflows slow.

Cash Flow

TD SYNNEX Corporation has a free cash flow margin of 2.2%, earning a moderate score of 33/100. The company generates positive cash flow after capital investments, but with room for improvement.

Returns

TD SYNNEX Corporation earns a strong 9.8% return on equity (ROE), meaning it generates $10 of profit for every $100 of shareholders' equity. This efficient capital use earns a returns score of 69/100. This is up from 8.6% the prior year.

Altman Z-Score Grey Zone

2.77

TD SYNNEX Corporation scores 2.77, placing it in the grey zone between 1.81 and 2.99. This signals moderate financial risk that warrants monitoring.

Distress-screening estimate for non-financial companies. Not computed for banks or insurers, where the Altman model does not apply.

Piotroski F-Score Strong

7/9

TD SYNNEX Corporation passes 7 of 9 financial strength tests. All 4 profitability signals pass (positive income, cash flow, and earnings quality), 2 of 3 leverage/liquidity signals pass, 1 of 2 efficiency signals pass.

Earnings Quality Cash-Backed

1.85x

For every $1 of reported earnings, TD SYNNEX Corporation generates $1.85 in operating cash flow ($1.5B OCF vs $827.7M net income). This indicates profits are well-supported by actual cash generation, not accounting adjustments.

Interest Coverage Adequate

3.97x

TD SYNNEX Corporation earns $3.97 in operating income for every $1 of interest expense ($1.4B vs $356.6M). This adequate coverage means the company can meet its interest obligations, but has limited cushion if earnings fall.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue

$21.6B

YoY+37.7%

QoQ+10.1%

5Y CAGR+32.9%

TD SYNNEX Corporation generated $21.6B in revenue in Q3 2026. This represents an increase of 37.7% from the same quarter a year earlier. Against the prior quarter it is up 10.1%.

EBITDA

$749.1M

YoY+53.0%

QoQ+19.9%

5Y CAGR+35.6%

TD SYNNEX Corporation's EBITDA was $749.1M in Q3 2026, measuring earnings before interest, taxes, depreciation, and amortization. This represents an increase of 53.0% from the same quarter a year earlier. Against the prior quarter it is up 19.9%.

Net Income

$416.2M

YoY+83.5%

QoQ+24.6%

5Y CAGR+34.5%

TD SYNNEX Corporation reported $416.2M in net income in Q3 2026. This represents an increase of 83.5% from the same quarter a year earlier. Against the prior quarter it is up 24.6%.

EPS (Diluted)

$5.18

YoY+89.1%

QoQ+24.8%

5Y CAGR+23.4%

10Y CAGR+13.4%

TD SYNNEX Corporation earned $5.18 per diluted share (EPS) in Q3 2026. This represents an increase of 89.1% from the same quarter a year earlier. Against the prior quarter it is up 24.8%.

Cash & Balance Sheet

Free Cash Flow

-$975.6M

YoY-556.1%

QoQ-193.5%

TD SYNNEX Corporation recorded an outflow of $975.6M in free cash flow in Q3 2026, representing a cash shortfall after capex. This represents a decrease of 556.1% from the same quarter a year earlier. Against the prior quarter it is down 193.5%.

Cash & Debt

$749.3M

YoY-14.3%

QoQ-31.5%

5Y CAGR-28.6%

10Y CAGR+12.9%

TD SYNNEX Corporation held $749.3M in cash against $3.6B in long-term debt as of Q3 2026.

Dividends Per Share

$0.48

YoY+9.1%

QoQ0.0%

5Y CAGR+19.1%

10Y CAGR+9.1%

TD SYNNEX Corporation paid $0.48 per share in dividends in Q3 2026. This represents an increase of 9.1% from the same quarter a year earlier. It is unchanged from the prior quarter.

Shares Outstanding

80M

YoY-2.0%

QoQ-0.2%

5Y CAGR-3.6%

10Y CAGR+7.2%

TD SYNNEX Corporation had 80M shares outstanding in Q3 2026. This represents a decrease of 2.0% from the same quarter a year earlier. Against the prior quarter it is down 0.2%.

Margins & Returns

Gross Margin

6.6%

YoY-0.6pp

QoQ-0.2pp

5Y change+0.6pp

TD SYNNEX Corporation's gross margin was 6.6% in Q3 2026, indicating the percentage of revenue retained after direct costs. This is down 0.6 percentage points from the same quarter a year earlier. Against the prior quarter it is down 0.2 percentage points.

Operating Margin

3.0%

YoY+0.5pp

QoQ+0.3pp

5Y change+0.1pp

TD SYNNEX Corporation's operating margin was 3.0% in Q3 2026, reflecting core business profitability. This is up 0.5 percentage points from the same quarter a year earlier. Against the prior quarter it is up 0.3 percentage points.

Net Margin

1.9%

YoY+0.5pp

QoQ+0.2pp

5Y change+0.1pp

TD SYNNEX Corporation's net profit margin was 1.9% in Q3 2026, showing the share of revenue converted to profit. This is up 0.5 percentage points from the same quarter a year earlier. Against the prior quarter it is up 0.2 percentage points.

Return on Equity

4.5%

YoY+1.8pp

QoQ+0.7pp

5Y change+0.4pp

TD SYNNEX Corporation's ROE was 4.5% in Q3 2026, measuring profit generated per dollar of shareholder equity. This is up 1.8 percentage points from the same quarter a year earlier. Against the prior quarter it is up 0.7 percentage points.

Capital Allocation

Share Buybacks

$100.3M

YoY-42.3%

QoQ-10.8%

TD SYNNEX Corporation spent $100.3M on share buybacks in Q3 2026, returning capital to shareholders by reducing shares outstanding. This represents a decrease of 42.3% from the same quarter a year earlier. Against the prior quarter it is down 10.8%.

Capital Expenditures

$58.9M

YoY+82.8%

QoQ-11.9%

5Y CAGR+63.8%

10Y CAGR+7.9%

TD SYNNEX Corporation invested $58.9M in capex in Q3 2026, funding long-term assets and infrastructure. This represents an increase of 82.8% from the same quarter a year earlier. Against the prior quarter it is down 11.9%.

R&D Spending

Not reported for Q3 2026.

SNX Income Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

SNX quarterly income statement

Metric	TTM	FY2510-K	FY2410-K	FY2310-K	FY2210-K	FY2110-K	FY2010-K	FY1910-K	FY1810-K	FY1710-K	FY1610-K	FY1510-K	FY1410-K	FY1310-K	FY1210-K	FY1110-K
Revenue	$75.7B	$62.5B+6.9%	$58.5B+1.6%	$57.6B-7.7%	$62.3B+97.2%	$31.6B+58.3%	$20.0B+4.8%	$19.1B+10.1%	$17.3B+777.2%	$2.0B+25.7%	$1.6B-88.2%	$13.3B-3.6%	$13.8B+27.6%	$10.8B+5.4%	$10.3B-1.2%	$10.4B
Cost of Revenue	$70.5B	$58.1B+6.7%	$54.5B+1.6%	$53.6B-8.3%	$58.4B+96.6%	$29.7B+58.3%	$18.8B+4.9%	$17.9B+1082.8%	$1.5B+22.9%	$1.2B+28.0%	$963.4M-91.5%	$11.3B-11.5%	$12.7B+25.0%	$10.2B+5.8%	$9.6B-1.5%	$9.8B
Gross Profit	$5.2B	$4.4B+9.7%	$4.0B+0.6%	$4.0B+1.5%	$3.9B+106.4%	$1.9B+58.3%	$1.2B+3.2%	$1.2B+16.1%	$996.6M-35.7%	$1.5B+20.8%	$1.3B+7.7%	$1.2B+8.4%	$1.1B+67.8%	$655.0M-0.3%	$656.7M+4.2%	$630.5M
SG&A Expenses	$3.2B	$2.9B+8.5%	$2.7B+1.6%	$2.7B+1.7%	$2.6B+127.6%	$1.2B+73.5%	$665.1M+4.4%	$636.8M+7.7%	$591.1M-43.3%	$1.0B+15.3%	$903.4M+7.9%	$837.2M+5.9%	$790.5M+90.9%	$414.1M+3.1%	$401.7M+7.3%	$374.3M
Operating Income	$2.1B	$1.4B+18.5%	$1.2B+10.8%	$1.1B+2.6%	$1.1B+68.6%	$623.2M+19.5%	$521.3M+0.4%	$519.4M+28.1%	$405.5M-20.1%	$507.3M+33.7%	$379.6M+7.1%	$354.6M+14.9%	$308.5M+28.1%	$240.8M-5.6%	$255.0M-0.5%	$256.2M
EBITDA	N/A	$1.8B+14.2%	$1.6B+7.0%	$1.5B-1.2%	$1.5B+95.4%	$774.9M-10.2%	$863.0M-3.2%	$891.5M+41.3%	$630.8M-5.5%	$667.2M+33.2%	$500.9M+9.3%	$458.1M+14.5%	$400.2M+50.9%	$265.3M-5.1%	$279.6M-0.4%	$280.9M
Interest Expense	$320.8M	$356.6M+11.6%	$319.5M+10.8%	$288.3M+29.5%	$222.6M+41.0%	$157.8M+20.7%	$130.8M-23.9%	$171.9M+86.9%	$92.0M+94.3%	$47.4M+52.2%	$31.1M+11.4%	$27.9M-0.3%	$28.0M+37.1%	$20.4M-26.0%	$27.6M-4.1%	$28.8M
Income Tax	$393.0M	$229.6M+29.8%	$176.9M+8.8%	$162.6M-7.5%	$175.8M+146.2%	$71.4M-29.7%	$101.6M-8.6%	$111.1M+9.9%	$101.1M-37.9%	$162.9M+34.5%	$121.1M+2.1%	$118.6M+13.9%	$104.1M+21.5%	$85.7M+2.0%	$84.0M+6.2%	$79.2M
Net Income	$1.3B	$827.7M+20.1%	$689.1M+9.9%	$626.9M-3.7%	$651.3M+64.9%	$395.1M-25.3%	$529.2M+5.7%	$500.7M+66.9%	$300.0M-0.1%	$300.2M+27.8%	$234.9M+12.7%	$208.5M+15.8%	$180.0M+18.3%	$152.2M+0.6%	$151.4M+0.7%	$150.3M
EPS (Basic)	N/A	$9.99+25.0%	$7.99+18.9%	$6.72-1.0%	$6.79+8.1%	$6.28-38.9%	$10.28+5.0%	$9.79+35.8%	$7.21-4.1%	$7.52+27.2%	$5.91+11.9%	$5.28+14.5%	$4.61+13.5%	$4.06-0.5%	$4.08-2.9%	$4.20
EPS (Diluted)	$16.40	$9.95+25.2%	$7.95+18.7%	$6.70-1.0%	$6.77	$6.24	$10.21+4.8%	$9.74+35.8%	$7.17-4.1%	$7.48+27.2%	$5.88+12.2%	$5.24+14.7%	$4.57+51.3%	$3.02-23.7%	$3.96-2.9%	$4.08
Diluted Shares (Avg)	N/A	82M-4.0%	86M-7.5%	93M-2.8%	96M	63M	51M+0.6%	51M+22.9%	41M+4.3%	40M+0.6%	40M+0.5%	39M+1.3%	39M+3.2%	38M-0.3%	38M+2.5%	37M

Metric	Q3'2610-Q	Q2'2610-Q	Q1'2610-Q	Q4'2510-Q	Q3'2510-Q	Q2'2510-Q	Q1'2510-Q	Q4'2410-K
Revenue	$21.6B+37.7%	$19.6B+31.0%	$17.2B+18.1%	$17.4B+9.7%	$15.7B+6.6%	$14.9B+7.2%	$14.5B+4.0%	$15.8B+10.0%
Cost of Revenue	$20.1B+38.6%	$18.2B+31.2%	$15.9B+17.6%	$16.2B+9.3%	$14.5B+5.8%	$13.9B+7.1%	$13.5B+4.4%	$14.8B+10.6%
Gross Profit	$1.4B+26.2%	$1.3B+28.0%	$1.3B+25.5%	$1.2B+14.8%	$1.1B+17.6%	$1.0B+7.5%	$998.0M-0.8%	$1.0B+2.2%
SG&A Expenses	$782.5M+4.9%	$820.1M+14.2%	$762.8M+10.0%	$788.9M+10.3%	$746.2M+13.5%	$718.2M+6.9%	$693.5M+3.3%	$715.0M+4.4%
Operating Income	$642.9M+67.6%	$519.4M+58.3%	$489.4M+60.7%	$398.7M+22.7%	$383.7M+26.7%	$328.1M+24.3%	$304.5M+0.6%	$324.8M+13.3%
EBITDA	$749.1M+53.0%	$624.6M+44.7%	$594.0M+47.0%	$503.7M+17.9%	$489.5M+22.0%	$431.7M+16.6%	$404.2M+0.2%	$427.3M+9.5%
Interest Expense	-$120.5M-32.2%	-$97.8M-8.7%	-$86.5M+1.5%	$625.7M+624.0%	-$91.2M-213.4%	-$90.0M-217.3%	-$87.9M-215.8%	$86.4M+30.7%
Income Tax	$139.0M+109.1%	$95.8M+80.3%	$95.5M+101.7%	$62.6M+47.8%	$66.5M+56.9%	$53.2M+31.1%	$47.3M-8.4%	$42.4M+7.1%
Net Income	$416.2M+83.5%	$334.1M+80.7%	$326.9M+95.1%	$248.4M+27.5%	$226.8M+27.0%	$184.9M+28.8%	$167.5M-2.7%	$194.8M+3.9%
EPS (Basic)	$5.20+88.4%	$4.16+87.4%	$4.05+104.5%	$3.04+32.8%	$2.76+32.1%	$2.22+32.9%	$1.98+2.1%	$2.29+11.7%
EPS (Diluted)	$5.18+89.1%	$4.15+87.8%	$4.04+104.0%	$3.03+32.9%	$2.74+31.7%	$2.21+33.1%	$1.98+2.6%	$2.28+11.8%
Diluted Shares (Avg)	79M-3.0%	80M-3.8%	80M-4.5%	N/A	82M-3.6%	83M-3.4%	84M-4.8%	N/A

Not reported in any period shown, so not listed: R&D Expenses.

SNX Balance Sheet

SNX quarterly balance sheet

Metric	FY2510-K	FY2410-K	FY2310-K	FY2210-K	FY2110-K	FY2010-K	FY1910-K	FY1810-K	FY1710-K	FY1610-K	FY1510-K	FY1410-K	FY1310-K	FY1210-K	FY1110-K
Total Assets	$34.3B+13.1%	$30.3B+2.9%	$29.4B-1.1%	$29.7B+7.5%	$27.7B+105.4%	$13.5B+15.1%	$11.7B+1.3%	$11.5B+48.8%	$7.8B+48.7%	$5.2B+17.4%	$4.4B-5.7%	$4.7B+41.7%	$3.3B+12.2%	$3.0B+4.6%	$2.8B
Current Assets	$25.3B+18.6%	$21.3B+6.2%	$20.1B-2.0%	$20.5B+15.6%	$17.7B+102.2%	$8.8B+17.7%	$7.5B+4.1%	$7.2B+24.8%	$5.7B+43.7%	$4.0B+9.5%	$3.6B-6.4%	$3.9B+33.0%	$2.9B+13.6%	$2.6B+5.8%	$2.4B
Cash & Equivalents	$2.4B+129.9%	$1.1B+2.5%	$1.0B+97.8%	$522.6M-47.4%	$994.0M-29.6%	$1.4B+868.0%	$145.9M-67.9%	$454.7M-17.4%	$550.7M+44.6%	$380.7M+13.3%	$336.1M+86.6%	$180.1M+18.8%	$151.6M-7.4%	$163.7M+142.3%	$67.6M
Short-Term Investments	$0	$0	$0	$0	$0	$0	$0-100.0%	$2.6M-52.9%	$5.5M+7.2%	$5.1M-7.9%	$5.5M-22.2%	$7.1M-52.9%	$15.1M-5.0%	$15.9M-0.5%	$16.0M
Inventory	$9.5B+14.7%	$8.3B+16.0%	$7.1B-21.2%	$9.1B+36.5%	$6.6B+147.5%	$2.7B+5.4%	$2.5B+6.4%	$2.4B+10.6%	$2.2B+24.2%	$1.7B+31.1%	$1.3B-5.0%	$1.4B+27.7%	$1.1B+18.6%	$923.3M-5.3%	$975.0M
Accounts Receivable	$11.7B+13.2%	$10.3B+0.4%	$10.3B+9.3%	$9.4B+13.4%	$8.3B+197.7%	$2.8B-6.8%	$3.0B-17.7%	$3.6B+27.9%	$2.8B+62.0%	$1.8B-0.2%	$1.8B-15.9%	$2.1B+31.3%	$1.6B+13.7%	$1.4B+8.4%	$1.3B
Long-Term Investments	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0
Goodwill	$4.1B+5.2%	$3.9B-0.2%	$3.9B+2.6%	$3.8B-2.9%	$3.9B+824.1%	$423.9M-0.3%	$425.1M-0.6%	$427.8M-51.0%	$872.6M+79.5%	$486.2M+62.7%	$298.8M-4.9%	$314.2M+66.7%	$188.5M-0.3%	$189.1M+2.0%	$185.3M
Total Liabilities	$25.8B+16.0%	$22.2B+4.8%	$21.2B-2.2%	$21.7B+9.9%	$19.8B+116.4%	$9.1B+15.4%	$7.9B-2.5%	$8.1B+49.7%	$5.4B+67.2%	$3.2B+22.5%	$2.6B-13.6%	$3.1B+59.8%	$1.9B+16.4%	$1.6B-1.3%	$1.7B
Current Liabilities	$21.0B+21.7%	$17.2B+2.9%	$16.7B+1.9%	$16.4B+15.4%	$14.2B+152.8%	$5.6B+22.2%	$4.6B-7.0%	$5.0B+22.6%	$4.0B+63.2%	$2.5B+29.1%	$1.9B-29.5%	$2.7B+52.1%	$1.8B+19.7%	$1.5B+8.9%	$1.4B
Non-Current Liabilities	$4.8B-3.6%	$5.0B+11.7%	$4.5B-14.9%	$5.3B-4.5%	$5.5B+57.9%	$3.5B+6.0%	$3.3B+4.7%	$3.2B+129.7%	$1.4B+80.0%	$763.0M+5.1%	$726.1M+115.2%	$337.3M+170.1%	$124.9M-16.3%	$149.2M-49.0%	$292.6M
Long-Term Debt	$3.6B-3.9%	$3.7B+20.6%	$3.1B-19.2%	$3.8B-3.0%	$4.0B+164.3%	$1.5B-44.9%	$2.7B+3.6%	$2.6B+130.9%	$1.1B+89.0%	$601.1M-5.9%	$638.8M+141.7%	$264.2M+304.0%	$65.4M-19.4%	$81.2M-63.7%	$223.8M
Total Equity	$8.5B+5.2%	$8.0B-1.8%	$8.2B+2.0%	$8.0B+1.5%	$7.9B+82.2%	$4.3B+14.5%	$3.8B+10.3%	$3.4B+50.2%	$2.3B+15.8%	$2.0B+9.8%	$1.8B+8.8%	$1.7B+17.2%	$1.4B+7.0%	$1.3B+13.9%	$1.2B
Retained Earnings	$3.4B+24.7%	$2.8B+25.0%	$2.2B+29.1%	$1.7B+45.8%	$1.2B-62.6%	$3.1B+19.4%	$2.6B+19.4%	$2.2B+12.5%	$2.0B+15.3%	$1.7B+13.5%	$1.5B+14.2%	$1.3B+15.5%	$1.1B+15.5%	$980.9M+18.2%	$829.5M

Metric	Q3'2610-Q	Q2'2610-Q	Q1'2610-Q	Q4'2510-Q	Q3'2510-Q	Q2'2510-Q	Q1'2510-Q	Q4'2410-K
Total Assets	$41.8B+32.1%	$38.5B+26.2%	$35.1B+21.8%	$34.3B+13.1%	$31.7B+8.5%	$30.5B+10.1%	$28.8B+3.6%	$30.3B+2.9%
Current Assets	$32.9B+45.7%	$29.6B+37.7%	$26.1B+30.8%	$25.3B+18.6%	$22.6B+12.6%	$21.5B+15.7%	$20.0B+7.4%	$21.3B+6.2%
Cash & Equivalents	$749.3M-14.3%	$1.1B+42.6%	$1.6B+188.4%	$2.4B+129.9%	$874.4M+2.4%	$767.1M-34.6%	$541.9M-47.4%	$1.1B+2.5%
Short-Term Investments	$0	$0	$0	$0	$0	$0	$0	$0
Inventory	$15.3B+67.3%	$13.9B+60.5%	$11.0B+31.4%	$9.5B+14.7%	$9.1B+19.1%	$8.7B+21.9%	$8.4B+17.9%	$8.3B+16.0%
Accounts Receivable	$15.0B+36.9%	$13.0B+28.3%	$11.9B+26.7%	$11.7B+13.2%	$10.9B+8.9%	$10.1B+14.4%	$9.4B+5.9%	$10.3B+0.4%
Long-Term Investments	$0	$0	$0	$0	$0	$0	$0	$0
Goodwill	$4.1B+0.1%	$4.1B+3.0%	$4.1B+6.5%	$4.1B+5.2%	$4.1B+3.8%	$4.0B+2.4%	$3.9B-0.6%	$3.9B-0.2%
Total Liabilities	$32.5B+40.1%	$29.6B+33.3%	$26.3B+26.8%	$25.8B+16.0%	$23.2B+10.4%	$22.2B+12.2%	$20.7B+5.3%	$22.2B+4.8%
Current Liabilities	$27.6B+46.2%	$24.7B+44.1%	$21.4B+36.3%	$21.0B+21.7%	$18.9B+18.1%	$17.1B+16.5%	$15.7B+3.1%	$17.2B+2.9%
Non-Current Liabilities	$4.9B+13.5%	$4.9B-3.2%	$4.9B-3.0%	$4.8B-3.6%	$4.3B-13.9%	$5.0B-0.2%	$5.0B+12.8%	$5.0B+11.7%
Long-Term Debt	$3.6B+18.1%	$3.6B-3.5%	$3.6B-3.9%	$3.6B-3.9%	$3.0B-18.5%	$3.7B-0.3%	$3.7B+21.2%	$3.7B+20.6%
Total Equity	$9.3B+10.0%	$9.0B+7.3%	$8.8B+9.1%	$8.5B+5.2%	$8.5B+3.5%	$8.3B+4.9%	$8.1B-0.6%	$8.0B-1.8%
Retained Earnings	$4.4B+36.4%	$4.0B+32.5%	$3.7B+29.1%	$3.4B+24.7%	$3.2B+24.3%	$3.0B+23.8%	$2.9B+23.3%	$2.8B+25.0%

SNX Cash Flow Statement

SNX quarterly cash flow statement

Metric	TTM	FY2510-K	FY2410-K	FY2310-K	FY2210-K	FY2110-K	FY2010-K	FY1910-K	FY1810-K	FY1710-K	FY1610-K	FY1510-K	FY1410-K	FY1310-K	FY1210-K	FY1110-K
Operating Cash Flow	-$617.8M	$1.5B+25.8%	$1.2B-13.5%	$1.4B+2937.2%	-$49.6M-106.1%	$809.8M-55.9%	$1.8B+233.6%	$549.9M+446.1%	$100.7M-43.0%	$176.8M-45.6%	$324.7M-49.4%	$641.3M+373.2%	-$234.8M-757.5%	$35.7M-85.3%	$242.8M+10.8%	$219.2M
Depreciation & Amortization	N/A	$414.2M+1.6%	$407.5M-2.6%	$418.3M-9.7%	$463.4M+205.5%	$151.7M-55.6%	$341.6M-8.2%	$372.1M+65.2%	$225.3M+40.9%	$159.9M+31.8%	$121.3M+17.2%	$103.5M+12.9%	$91.7M+274.9%	$24.5M-0.7%	$24.6M-0.2%	$24.7M
Stock-Based Compensation	N/A	$66.4M-4.0%	$69.2M-18.6%	$85.0M-6.8%	$91.2M+71.4%	$53.2M+60.2%	$33.2M+18.8%	$28.0M+23.3%	$22.7M+30.6%	$17.4M+24.3%	$14.0M+2.4%	$13.6M-3.1%	$14.1M+53.4%	$9.2M+8.6%	$8.4M+5.7%	$8.0M
Capital Expenditures	$197.1M	$142.3M-18.7%	$175.1M+16.7%	$150.0M+129.8%	$65.3M+64.5%	$39.7M+49.0%	$26.6M-80.6%	$137.4M+9.7%	$125.3M+28.5%	$97.5M-20.8%	$123.2M+23.1%	$100.1M+74.5%	$57.4M+98.1%	$29.0M+100.0%	$14.5M-63.9%	$40.2M
Free Cash Flow	-$815.0M	$1.4B+33.3%	$1.0B-17.1%	$1.3B+1194.4%	-$114.9M-114.9%	$770.1M-57.4%	$1.8B+338.2%	$412.5M+1776.9%	-$24.6M-131.1%	$79.2M-60.7%	$201.5M-62.8%	$541.2M+285.3%	-$292.1M-4433.3%	$6.7M-97.0%	$228.3M+27.5%	$179.0M
Investing Cash Flow	-$190.8M	-$221.2M-14.1%	-$193.8M-23.9%	-$156.4M-35.4%	-$115.5M+87.9%	-$952.3M-354.6%	-$209.5M-42.7%	-$146.8M+87.6%	-$1.2B-80.3%	-$654.3M-23.0%	-$531.9M-794.7%	-$59.4M+86.5%	-$441.7M-908.7%	-$43.8M-358.0%	-$9.6M+92.4%	-$126.4M
Financing Cash Flow	$681.3M	-$32.9M+96.6%	-$953.1M-21.3%	-$785.9M-185.2%	-$275.6M+29.8%	-$392.6M-34.6%	-$291.7M+53.8%	-$631.7M-163.1%	$1.0B+56.8%	$638.7M+254.5%	$180.2M+150.7%	-$355.1M-150.6%	$701.9M+8490.2%	-$8.4M+93.9%	-$137.5M-20.1%	-$114.4M
Dividends Paid	$151.6M	$146.4M+6.0%	$138.1M+5.9%	$130.4M+13.4%	$114.9M+128.6%	$50.3M+141.9%	$20.8M-72.9%	$76.6M+28.3%	$59.7M+42.8%	$41.8M+24.0%	$33.7M+49.3%	$22.6M+358.5%	$4.9M	$0	$0	N/A
Share Buybacks	$465.3M	$596.1M-2.6%	$611.9M-1.4%	$620.7M+396.5%	$125.0M	$0-100.0%	$3.4M-77.6%	$15.2M-77.0%	$66.0M	$0-100.0%	$6.9M-20.8%	$8.7M	$0-100.0%	$1.9M-75.8%	$7.8M+364.3%	$1.7M

Metric	Q3'2610-Q	Q2'2610-Q	Q1'2610-Q	Q4'2510-Q	Q3'2510-Q	Q2'2510-Q	Q1'2510-Q	Q4'2410-K
Operating Cash Flow	-$916.7M-472.4%	-$265.6M-146.3%	-$895.9M-19.8%	$1.5B+159.9%	$246.1M-36.2%	$573.2M+599.7%	-$748.0M-294.4%	$561.9M+166.7%
Depreciation & Amortization	$106.2M+0.4%	$105.3M+1.6%	$104.7M+5.0%	$105.1M+2.6%	$105.8M+7.8%	$103.6M-2.5%	$99.7M-0.9%	$102.4M-0.9%
Stock-Based Compensation	$16.3M+30.8%	$17.9M+49.6%	$23.6M+8.2%	N/A	$12.4M-23.2%	$11.9M-11.0%	$21.9M+25.0%	N/A
Capital Expenditures	$58.9M+82.8%	$66.8M+121.0%	$33.1M-20.2%	$38.3M-21.9%	$32.2M-31.7%	$30.2M-20.0%	$41.5M+1.1%	$49.1M+15.2%
Free Cash Flow	-$975.6M-556.1%	-$332.4M-161.2%	-$929.0M-17.7%	$1.4B+177.3%	$213.9M-36.8%	$542.9M+456.0%	-$789.5M-329.8%	$512.9M+205.1%
Investing Cash Flow	-$80.9M+23.4%	-$53.9M-102.9%	-$11.6M+74.0%	-$44.4M-262.1%	-$105.7M-30.8%	-$26.5M+19.3%	-$44.5M+34.4%	-$12.3M+71.6%
Financing Cash Flow	$660.1M+1211.9%	-$139.5M+66.4%	$7.6M-97.4%	$153.1M+151.4%	-$59.4M+90.7%	-$415.2M-241.4%	$288.6M+192.7%	-$297.7M+21.7%
Dividends Paid	$38.4M+5.7%	$38.5M+4.4%	$38.7M+4.1%	$36.0M+5.7%	$36.3M+6.1%	$36.9M+7.9%	$37.2M+4.4%	$34.0M+8.1%
Share Buybacks	$100.3M-42.3%	$112.4M-24.5%	$79.7M-20.7%	$173.0M+69.6%	$173.8M+207.6%	$148.8M-41.4%	$100.5M-49.5%	$102.0M-70.3%

SNX Financial Ratios

Margins and returns are percentages; the remaining ratios are unitless multiples. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

SNX quarterly financial ratios

Metric	FY2510-K	FY2410-K	FY2310-K	FY2210-K	FY2110-K	FY2010-K	FY1910-K	FY1810-K	FY1710-K	FY1610-K	FY1510-K	FY1410-K	FY1310-K	FY1210-K	FY1110-K
Gross Margin	7.0%+0.2pp	6.8%-0.1pp	6.9%+0.6pp	6.3%+0.3pp	6.0%0.0pp	6.0%-0.1pp	6.1%+0.3pp	5.8%-72.7pp	78.5%-3.2pp	81.6%+72.7pp	8.9%+1.0pp	7.9%+1.9pp	6.0%-0.3pp	6.4%+0.3pp	6.1%
Operating Margin	2.3%+0.2pp	2.0%+0.2pp	1.9%+0.2pp	1.7%-0.3pp	2.0%-0.6pp	2.6%-0.1pp	2.7%+0.4pp	2.3%-23.4pp	25.7%+1.5pp	24.2%+21.5pp	2.7%+0.4pp	2.2%0.0pp	2.2%-0.3pp	2.5%0.0pp	2.5%
Net Margin	1.3%+0.1pp	1.2%+0.1pp	1.1%+0.1pp	1.0%-0.2pp	1.3%-1.4pp	2.6%0.0pp	2.6%+0.9pp	1.7%-13.5pp	15.2%+0.3pp	14.9%+13.4pp	1.6%+0.3pp	1.3%-0.1pp	1.4%-0.1pp	1.5%0.0pp	1.4%
Return on Equity	9.8%+1.2pp	8.6%+0.9pp	7.7%-0.5pp	8.1%+3.1pp	5.0%-7.2pp	12.2%-1.0pp	13.2%+4.5pp	8.7%-4.4pp	13.1%+1.2pp	11.9%+0.3pp	11.6%+0.7pp	10.9%+0.1pp	10.8%-0.7pp	11.5%-1.5pp	13.0%
Return on Assets	2.4%+0.1pp	2.3%+0.2pp	2.1%-0.1pp	2.2%+0.8pp	1.4%-2.5pp	3.9%-0.3pp	4.3%+1.7pp	2.6%-1.3pp	3.9%-0.6pp	4.5%-0.2pp	4.7%+0.9pp	3.8%-0.8pp	4.6%-0.5pp	5.1%-0.2pp	5.3%
Current Ratio	1.210.0x	1.240.0x	1.200.0x	1.250.0x	1.25-0.3x	1.56-0.1x	1.62+0.2x	1.450.0x	1.42-0.2x	1.61-0.3x	1.90+0.5x	1.43-0.2x	1.64-0.1x	1.73-0.1x	1.78
Debt-to-Equity	0.430.0x	0.47+0.1x	0.38-0.1x	0.480.0x	0.50+0.2x	0.34-0.4x	0.720.0x	0.76+0.3x	0.50+0.2x	0.30-0.1x	0.35+0.2x	0.16+0.1x	0.050.0x	0.06-0.1x	0.19
Asset Turnover	1.82-0.1x	1.930.0x	1.96-0.1x	2.10+1.0x	1.14-0.3x	1.48-0.1x	1.63+0.1x	1.50+1.2x	0.250.0x	0.30-2.7x	3.00+0.1x	2.94-0.3x	3.26-0.2x	3.47-0.2x	3.67
FCF Margin	2.2%+0.4pp	1.8%-0.4pp	2.2%+2.4pp	-0.2%-2.6pp	2.4%-6.6pp	9.0%+6.9pp	2.2%+2.3pp	-0.1%-4.1pp	4.0%-8.8pp	12.8%+8.8pp	4.1%+6.2pp	-2.1%-2.2pp	0.1%-2.2pp	2.2%+0.5pp	1.7%

Metric	Q3'2610-Q	Q2'2610-Q	Q1'2610-Q	Q4'2510-Q	Q3'2510-Q	Q2'2510-Q	Q1'2510-Q	Q4'2410-K
Gross Margin	6.6%-0.6pp	6.8%-0.2pp	7.3%+0.4pp	6.9%+0.3pp	7.2%+0.7pp	7.0%0.0pp	6.9%-0.3pp	6.6%-0.5pp
Operating Margin	3.0%+0.5pp	2.6%+0.5pp	2.9%+0.8pp	2.3%+0.2pp	2.5%+0.4pp	2.2%+0.3pp	2.1%-0.1pp	2.1%+0.1pp
Net Margin	1.9%+0.5pp	1.7%+0.5pp	1.9%+0.8pp	1.4%+0.2pp	1.5%+0.2pp	1.2%+0.2pp	1.1%-0.1pp	1.2%-0.1pp
Return on Equity	4.5%+1.8pp	3.7%+1.5pp	3.7%+1.6pp	2.9%+0.5pp	2.7%+0.5pp	2.2%+0.4pp	2.1%0.0pp	2.4%+0.1pp
Return on Assets	1.0%+0.3pp	0.9%+0.3pp	0.9%+0.3pp	0.7%+0.1pp	0.7%+0.1pp	0.6%+0.1pp	0.6%0.0pp	0.6%0.0pp
Current Ratio	1.190.0x	1.20-0.1x	1.22-0.1x	1.210.0x	1.20-0.1x	1.260.0x	1.27+0.1x	1.240.0x
Debt-to-Equity	0.390.0x	0.400.0x	0.41-0.1x	0.430.0x	0.36-0.1x	0.450.0x	0.46+0.1x	0.47+0.1x
Asset Turnover	0.520.0x	0.510.0x	0.490.0x	0.510.0x	0.490.0x	0.490.0x	0.500.0x	0.520.0x
FCF Margin	-4.5%-5.9pp	-1.7%-5.3pp	-5.4%0.0pp	8.2%+4.9pp	1.4%-0.9pp	3.6%+4.7pp	-5.4%-7.9pp	3.2%+2.1pp

Similar Companies

Newest fiscal year on record for each company. The health score is the peer-relative Financial Health Score for that year; a dash means no score is published for it.

Company	Fiscal year	Revenue	Net income	Net margin	Market cap	Health score
TD SYNNEX Corporation SNX	FY2025	$62.5B	$827.7M	1.3%	$22.0B	48/100
Arrow Electronics, Inc. ARW	FY2025	$30.9B	$571.3M	1.8%	$11.8B	37/100
Avnet, Inc. AVT	FY2026	$27.6B	$334.4M	1.2%	$8.2B	42/100
Insight Enterprises Inc NSIT	FY2025	$8.2B	$157.3M	1.9%	$5.2B	42/100
IonQ, Inc. IONQ	FY2025	$130.0M	-$510.0M	N/A	$14.1B	59/100
Logitech International SA LOGI	FY2026	$4.8B	$711.2M	14.7%	$14.7B	72/100

Where TD SYNNEX Corporation Ranks

Frequently Asked Questions

What is TD SYNNEX Corporation's annual revenue?

TD SYNNEX Corporation (SNX) reported $62.5B in total revenue for fiscal year 2025. This represents a 6.9% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

How fast is TD SYNNEX Corporation's revenue growing?

TD SYNNEX Corporation (SNX) revenue grew by 6.9% year-over-year, from $58.5B to $62.5B in fiscal year 2025.

Is TD SYNNEX Corporation profitable?

Yes, TD SYNNEX Corporation (SNX) reported a net income of $827.7M in fiscal year 2025, with a net profit margin of 1.3%.

What is TD SYNNEX Corporation's EBITDA?

TD SYNNEX Corporation (SNX) had EBITDA of $1.8B in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.

How much debt does TD SYNNEX Corporation have?

As of fiscal year 2025, TD SYNNEX Corporation (SNX) had $2.4B in cash and equivalents against $3.6B in long-term debt.

What is TD SYNNEX Corporation's gross margin?

TD SYNNEX Corporation (SNX) had a gross margin of 7.0% in fiscal year 2025, indicating the percentage of revenue retained after direct costs of goods sold.

What is TD SYNNEX Corporation's operating margin?

TD SYNNEX Corporation (SNX) had an operating margin of 2.3% in fiscal year 2025, reflecting the profitability of core business operations before interest and taxes.

What is TD SYNNEX Corporation's net profit margin?

TD SYNNEX Corporation (SNX) had a net profit margin of 1.3% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.

Does TD SYNNEX Corporation pay dividends?

Yes, TD SYNNEX Corporation (SNX) paid $1.76 per share in dividends during fiscal year 2025.

What is TD SYNNEX Corporation's return on equity (ROE)?

TD SYNNEX Corporation (SNX) has a return on equity of 9.8% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.

What is TD SYNNEX Corporation's free cash flow?

TD SYNNEX Corporation (SNX) generated $1.4B in free cash flow during fiscal year 2025. This represents a 33.3% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.

What is TD SYNNEX Corporation's operating cash flow?

TD SYNNEX Corporation (SNX) generated $1.5B in operating cash flow during fiscal year 2025, representing cash generated from core business activities.

What are TD SYNNEX Corporation's total assets?

TD SYNNEX Corporation (SNX) had $34.3B in total assets as of fiscal year 2025, including both current and long-term assets.

What are TD SYNNEX Corporation's capital expenditures?

TD SYNNEX Corporation (SNX) invested $142.3M in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.

Does TD SYNNEX Corporation buy back shares?

Yes, TD SYNNEX Corporation (SNX) spent $596.1M on share buybacks during fiscal year 2025, returning capital to shareholders by reducing shares outstanding.

How many shares does TD SYNNEX Corporation have outstanding?

TD SYNNEX Corporation (SNX) had 81M shares outstanding as of fiscal year 2025.

What is TD SYNNEX Corporation's current ratio?

TD SYNNEX Corporation (SNX) had a current ratio of 1.21 as of fiscal year 2025, which is considered adequate.

What is TD SYNNEX Corporation's debt-to-equity ratio?

TD SYNNEX Corporation (SNX) had a debt-to-equity ratio of 0.43 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.

What is TD SYNNEX Corporation's return on assets (ROA)?

TD SYNNEX Corporation (SNX) had a return on assets of 2.4% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.

What is TD SYNNEX Corporation's P/E ratio?

TD SYNNEX Corporation (SNX) trades at 16.6x earnings, its market capitalization divided by net income of $1.3B net income, trailing 12 months to August 31, 2026. The market capitalization is $22.0B as of Oct 14, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.

What is TD SYNNEX Corporation's price-to-sales ratio?

TD SYNNEX Corporation (SNX) trades at 0.3x sales, its market capitalization divided by revenue of $75.7B revenue, trailing 12 months to August 31, 2026. The market capitalization is $22.0B as of Oct 14, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.

What is TD SYNNEX Corporation's Altman Z-Score?

TD SYNNEX Corporation (SNX) has an Altman Z-Score of 2.77, placing it in the Grey Zone (moderate risk). The Z-Score combines five financial ratios (working capital, retained earnings, EBIT, market capitalization, and revenue relative to total assets) to predict the likelihood of bankruptcy. Scores above 2.99 indicate financial safety while scores below 1.81 suggest financial distress. Learn more in our complete guide to financial health indicators.

What is TD SYNNEX Corporation's Piotroski F-Score?

TD SYNNEX Corporation (SNX) has a Piotroski F-Score of 7 out of 9, indicating strong financial health. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

Are TD SYNNEX Corporation's earnings high quality?

TD SYNNEX Corporation (SNX) has an earnings quality ratio of 1.85x, considered cash-backed (high quality). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

Can TD SYNNEX Corporation cover its interest payments?

TD SYNNEX Corporation (SNX) has an interest coverage ratio of 3.97x, meaning it can adequately cover its interest obligations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.

How financially healthy is TD SYNNEX Corporation?

TD SYNNEX Corporation (SNX) scores 48 out of 100 on our Financial Health Score, indicating moderate standing within its operating companies peer group. The score is a 0-100 composite of six dimensions (Profitability, Growth, Leverage, Liquidity, Cash Flow, Returns), each ranked as a percentile relative to companies in the same scoring family (banks against banks, REITs against REITs, and so on) rather than across all industries. It rates the quality of the business, not whether the stock is fairly priced, and is not financial advice. Learn more in our complete guide to financial health indicators.